During 2020, Central America's imports of pharmaceutical products containing insulin totaled $35 million, and purchases from Danish companies increased 11% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
During 2020, companies in the region allocated $134 million for the import of vaccines for human use, and purchases from Russian companies increased 54% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
During 2020, Central American imports of pharmaceutical products totaled $3.502 billion, and purchases from Mexican companies increased by 2% over the amount reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
From January to September 2020, companies in the region invested $101 million for the purchase abroad of vaccines for human use, and purchases from Russian companies increased 34% compared to the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
From January to September 2020, Central American imports of pharmaceutical products totaled $2.625 billion, an amount that exceeds by just 0.4% what was reported in the same period of 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
During the first semester of 2020, companies from Central American countries bought abroad $23 million in vaccines for animal use, 18% more than what was reported for the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graph"]
From January to June 2020, companies in the region allocated $71 million for the purchase of human vaccines abroad, and 60% of imports were made by companies in Panama, Guatemala and Honduras.
Figures from the Trade Intelligence Area of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
Nicaragua, Costa Rica and Guatemala are the Central American markets that during the first half of 2020 and in year-on-year terms, increased their imports of pharmaceutical products.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
From January to July 2020, purchases of pharmaceutical products made by Central American countries from Mexican companies totaled $174 million, 7% more than what was reported for the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
From January to March 2020, companies in the region bought vaccines for human use abroad for $28 million, and 56% of total imports were made by companies in Costa Rica and Panama.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
From January to March 2020, pharmaceutical product imports in Central America totaled $825 million, with Costa Rica and Guatemala being the markets where purchases increased the most.
Figures from CentralAmericaData's Commercial Intelligence Unit: [GRAFICA caption="Click to interact with graphic"]
From January to March 2020, purchases of pharmaceutical products made by Central American countries from companies in Mexico totaled $73 million, 2% more than reported in the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
From January to September 2019, companies in the region bought vaccines for human use abroad for $154 million, 56% more than what was reported for the same period in 2018, a rise that is mainly explained by the behavior of imports in Panama.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics"]
From January to September 2019, pharmaceutical product imports in Central America totaled $2.614 million, 8% more than in the same period in 2018, with El Salvador, Panama and Costa Rica being the markets where purchases increased the most.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption "Click to interact with graphics"]
During the first semester of 2019, companies from Central American countries bought $20 million in vaccines for animal use abroad, and 55% was imported by companies in Guatemala and Costa Rica.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics"]